Impact of real-life use of artificial intelligence as support for human reading in a population-based breast cancer screening program with mammography and tomosynthesis

被引:11
作者
Elias-Cabot, Esperanza [1 ,2 ,3 ]
Romero-Martin, Sara [1 ,2 ,3 ]
Raya-Povedano, Jose Luis [1 ,2 ,3 ]
Brehl, A. -K. [4 ]
Alvarez-Benito, Marina [1 ,2 ,3 ]
机构
[1] Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain
[2] Reina Sofia Univ Hosp, Breast Canc Unit, Dept Diagnost Radiol, Menendez Pidal Ave S-N, Cordoba 14004, Spain
[3] Univ Cordoba, Cordoba, Spain
[4] ScreenPoint Med BV, Toernooiveld 300, NL-6525 EC Nijmegen, Netherlands
关键词
Artificial Intelligence; Mass screening; Mammography; Digital breast tomosynthesis; Breast neoplasms; ADVANCED RECTAL-CANCER; CHEMORADIATION THERAPY; COMPLETE RESPONSE; SOCIETY; MRI;
D O I
10.1007/s00330-023-10426-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives To evaluate the impact of using an artificial intelligence (AI) system as support for human double reading in a real-life scenario of a breast cancer screening program with digital mammography (DM) or digital breast tomosynthesis (DBT). Material and methods We analyzed the performance of double reading screening with mammography and tomosynthesis after implementarion of AI as decision support. The study group consisted of a consecutive cohort of 1 year screening between March 2021 and March 2022 where double reading was performed with concurrent AI support that automatically detects and highlights lesions suspicious of breast cancer in mammography and tomosynthesis. Screening performance was measured as cancer detection rate (CDR), recall rate (RR), and positive predictive value (PPV) of recalls. Performance in the study group was compared using a McNemar test to a control group that included a screening cohort of the same size, recorded just prior to the implementation of AI. Results A total of 11,998 women (mean age 57.59 years +/- 5.8 [sd]) were included in the study group (5049 DM and 6949 DBT). Comparing global results (including DM and DBT) of double reading with vs. without AI support, we observed an increase in CDR, PPV, and RR by 3.2/parts per thousand (5.8 vs. 9; p < 0.001), 4% (10.6 vs. 14.6; p < 0.001), and 0.7% (5.4 vs. 6.1; p < 0.001) respectively. Conclusion AI used as support for human double reading in a real-life breast cancer screening program with DM and DBT increases CDR and PPV of the recalled women. Clinical relevance statement Artificial intelligence as support for human double reading improves accuracy in a real-life breast cancer screening program both in digital mammography and digital breast tomosynthesis. Key Points center dot AI systems based on deep learning technology offer potential for improving breast cancer screening programs. center dot Using artificial intelligence as support for reading improves radiologists' performance in breast cancer screening programs with mammography or tomosynthesis. center dot Artificial intelligence used concurrently with human reading in clinical screening practice increases breast cancer detection rate and positive predictive value of the recalled women.
引用
收藏
页码:3958 / 3966
页数:9
相关论文
共 36 条
[1]   Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet [J].
Ancelle-Park, R. ;
Armaroli, P. ;
Ascunce, N. ;
Bisanti, L. ;
Bellisario, C. ;
Broeders, M. ;
Cogo, C. ;
de Koning, H. ;
Duffy, S. W. ;
Frigerio, A. ;
Giordano, L. ;
Hofvind, S. ;
Jonsson, H. ;
Lynge, E. ;
Massat, N. ;
Miccinesi, G. ;
Moss, S. ;
Naldoni, C. ;
Njor, S. ;
Nystrom, L. ;
Paap, E. ;
Paci, E. ;
Patnick, J. ;
Ponti, A. ;
Puliti, D. ;
Segnan, N. ;
Von Karsa, L. ;
Tornberg, S. ;
Zappa, M. ;
Zorzi, M. .
JOURNAL OF MEDICAL SCREENING, 2012, 19 :5-13
[2]  
Berger S, 2017, Working Papers, P2017
[3]   Early Prediction of Breast Cancer Recurrence for Patients Treated with Neoadjuvant Chemotherapy: A Transfer Learning Approach on DCE-MRIs [J].
Comes, Maria Colomba ;
La Forgia, Daniele ;
Didonna, Vittorio ;
Fanizzi, Annarita ;
Giotta, Francesco ;
Latorre, Agnese ;
Martinelli, Eugenio ;
Mencattini, Arianna ;
Paradiso, Angelo Virgilio ;
Tamborra, Pasquale ;
Terenzio, Antonella ;
Zito, Alfredo ;
Lorusso, Vito ;
Massafra, Raffaella .
CANCERS, 2021, 13 (10)
[4]   Improving Accuracy and Efficiency with Concurrent Use of Artificial Intelligence for Digital Breast Tomosynthesis [J].
Conant, Emily F. ;
Toledano, Alicia Y. ;
Periaswamy, Senthil ;
Fotin, Sergei, V ;
Go, Jonathan ;
Boatsman, Justin E. ;
Hoffmeister, Jeffrey W. .
RADIOLOGY-ARTIFICIAL INTELLIGENCE, 2019, 1 (04)
[5]  
Dembrower K, 2020, LANCET DIGIT HEALTH, V2, pE468, DOI 10.1016/S2589-7500(20)30185-0
[6]   Influence of computer-aided detection on performance of screening mammography [J].
Fenton, Joshua J. ;
Taplin, Stephen H. ;
Carney, Patricia A. ;
Abraham, Linn ;
Sickles, Edward A. ;
D'Orsi, Carl ;
Berns, Eric A. ;
Cutter, Gary ;
Hendrick, R. Edward ;
Barlow, William E. ;
Elmore, Joann G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (14) :1399-1409
[7]  
Ho DE, 2011, J STAT SOFTW, V42
[8]   True and Missed Interval Cancer in Organized Mammographic Screening: A Retrospective Review Study of Diagnostic and Prior Screening Mammograms [J].
Hovda, Tone ;
Hoff, Solveig Roth ;
Larsen, Marthe ;
Romundstad, Linda ;
Sahlberg, Kristine Kleivi ;
Hofvind, Solveig .
ACADEMIC RADIOLOGY, 2022, 29 :S180-S191
[9]   Changes in cancer detection and false-positive recall in mammography using artificial intelligence: a retrospective, multireader study [J].
Kim, Hyo-Eun ;
Kim, Hak Hee ;
Han, Boo-Kyung ;
Kim, Ki Hwan ;
Han, Kyunghwa ;
Nam, Hyeonseob ;
Lee, Eun Hye ;
Kim, Eun-Kyung .
LANCET DIGITAL HEALTH, 2020, 2 (03) :E138-E148
[10]   Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single- blinded, screening accuracy study [J].
Lang, Kristina ;
Josefsson, Viktoria ;
Larsson, Anna-Maria ;
Larsson, Stefan ;
Hogberg, Charlotte ;
Sartor, Hanna ;
Hofvind, Solveig ;
Andersson, Ingvar ;
Rosso, Aldana .
LANCET ONCOLOGY, 2023, 24 (08) :936-944